Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729248 · ClinicalTrials.gov registry record
The Differential Effects of 3 Different Immunosuppressive
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 12
- Enrollment target
NCT00729248 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 12 participants.
The verdict
NCT00729248 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The study is a laboratory investigation comparing the regulatory effects of different immunosuppressive therapies in an in vitro human MLR assay of selecting specific immunosuppressive therapy to promote a regulatory profile and determining possibly newer accepted dosing and drug concentrations for agents most associated with this regulatory profile.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00729248
The ClinicalTrials.gov registry entry for NCT00729248 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00729248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00729248 about?
NCT00729248 is a clinical study titled "The Differential Effects of 3 Different Immunosuppressive". The study is a laboratory investigation comparing the regulatory effects of different immunosuppressive therapies in an in vitro human MLR assay of selecting specific immunosuppressive therapy to promote a regulatory profile and determining possibly newer accepted dosing and drug concentrations for ...
What is the current status of trial NCT00729248?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2008-07. Estimated completion is 2010-01.
Who is sponsoring clinical trial NCT00729248?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.